3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
NIH
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Multiple Myeloma
420
Precursor Cell Lymphoblastic Leukemia-Lymphoma
126
Neoplasms, Plasma Cell
74
Recurrence
70
Lymphoma
57
Leukemia
54
Neoplasms
46
Immunoglobulin Light-chain Amyloidosis
38
Burkitt Lymphoma
37
Vomiting
36
Lymphoma, Mantle-Cell
32
Lymphoma, Large B-Cell, Diffuse
31
Nausea
29
Lymphoma, Non-Hodgkin
28
Breast Neoplasms
22
Waldenstrom Macroglobulinemia
21
Lymphoma, Follicular
21
Hodgkin Disease
21
Leukemia, Lymphocytic, Chronic, B-Cell
20
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
17
Neoplasm Metastasis
17
Prostatic Neoplasms
16
Lymphoma, Extranodal NK-T-Cell
16
Amyloidosis
16
Leukemia, Myeloid, Acute
15
Smoldering Multiple Myeloma
14
Lymphoma, B-Cell, Marginal Zone
13
Lung Neoplasms
11
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
10
Lymphoma, B-Cell
10
Interventions
Radiotherapy
24
Radiotherapy, Intensity-Modulated
8
Radiosurgery
6
Amifostine
5
Low-Level Light Therapy
4
Donepezil
4
Cisplatin
4
Carboplatin
4
Surveys and Questionnaires
3
Radiation
3
Proton Therapy
3
Paclitaxel
3
Neuropsychological Tests
3
Heavy Ion Radiotherapy
3
Etoposide
3
Chemotherapy, Adjuvant
3
Chemoradiotherapy
3
Brachytherapy
3
Bevacizumab
3
Surgical Procedures, Operative
2
Radiation Dose Hypofractionation
2
Patient Reported Outcome Measures
2
Mental Status and Dementia Tests
2
Esophagectomy
2
Androgen Antagonists
2
Adrenal Cortex Hormones
2
sodium propionate
1
sargramostim
1
olaparib
1
endostar protein
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Radiation Injuries
×
Dexamethasone
×
Clear all
NCT06888817
2026-02-25
BRAINS
The Netherlands Cancer Institute
Phase 3
Recruiting
408 enrolled